Medicine and Dentistry
Diabetic Neuropathy
100%
Polyneuropathy
56%
Muscle Strength
52%
Maturity Onset Diabetes of the Young
41%
Diabetes Mellitus
36%
Diabetes
32%
Immunoglobulin
30%
Myasthenia gravis
28%
Chronic Inflammatory Demyelinating Polyneuropathy
25%
Prevalence
21%
Nerve Conduction Study
17%
Glycogen Storage Disease Type II
17%
Muscle Weakness
16%
Peripheral Nerve
15%
Weakness
15%
Cross Sectional Study
15%
Patient Registry
14%
Magnetic Resonance Imaging
14%
Isometrics
12%
Stereotypic Movement Disorder
12%
Odds Ratio
12%
Dynamometry
11%
Polyradiculoneuropathy
11%
Diagnostic Criterion
11%
Autonomic Dysfunction
10%
Skeletal Muscle
10%
Sural Nerve
10%
Muscle Function
10%
Insulin Dependent Diabetes Mellitus
9%
Respiratory Failure
9%
Apoplexy
9%
Resistance Training
9%
Diffusion Tensor Imaging
8%
Electrodiagnosis
8%
Motor Performance
8%
Motor Unit Number Estimation
8%
DeJerine-Sottas Disease
8%
Multifocal Motor Neuropathy
8%
Amyotrophic Lateral Sclerosis
8%
Prospective Cohort Study
8%
Enzyme Replacement Therapy
7%
Muscle Fatigue
7%
Muscle Atrophy
7%
Maintenance Therapy
7%
Motor Unit
7%
Tibial Nerve
7%
Physical Disease by Body Function
7%
Randomized Controlled Trial
7%
Placebo
7%
Striated Muscle
6%
Keyphrases
Diabetic Neuropathy
72%
Myasthenia Gravis
40%
Type 2 Diabetes Mellitus (T2DM)
39%
Denmark
36%
Guillain-Barré Syndrome
31%
Muscle Strength
30%
Polyneuropathy
21%
Chronic Inflammatory Demyelinating Polyneuropathy
20%
Diabetes
16%
Ankle
16%
Subcutaneous Immunoglobulin
14%
Confidence Interval
14%
Nerve Conduction Studies
12%
Peripheral Nerve
12%
Healthy Controls
12%
Risk Factors
12%
Population-based
11%
Type 2 Diabetic Patients
11%
Motor Unit number Index (MUNIX)
11%
Amyotrophic Lateral Sclerosis
11%
Pompe Disease
11%
Nerve
11%
Danish National Patient Registry
10%
Diffusion Tensor Imaging
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Incidence Rate
10%
Knee Extensors
10%
Muscle Weakness
10%
Motor Function
9%
Aerobic Training
8%
Resistance Training
8%
Myotonic Dystrophy
8%
MScanFit
8%
Rozanolixizumab
8%
Fast-acting Insulin Aspart
8%
Muscle Velocity Recovery Cycles
8%
Diagnostic Codes
8%
Cross-sectional Area
8%
Knee Flexion
8%
Nerve Conduction
7%
Open-label Extension
7%
Placebo
7%
Diabetic Peripheral Neuropathy
7%
Diagnostic Criteria
7%
Odds Ratio
7%
Hazard Ratio
7%
Acetylcholine Receptor Antibody
7%
Reinnervation
7%
Sciatic Nerve
7%
Screen-detected
6%
Neuroscience
Polyneuropathy
80%
Diabetic Neuropathy
72%
Diabetes Mellitus
55%
Intravenous Immunoglobulin
31%
Nerve Conduction Study
31%
Myasthenia gravis
28%
Plantar Flexors
22%
Motor Unit
17%
Cerebrovascular Accident
15%
Stereotypic Movement Disorder
14%
Peripheral Nerve
13%
Electromyography
12%
Magnetic Resonance Imaging
12%
Magnetic Resonance Imaging
11%
Electrodiagnosis
11%
Amyotrophic Lateral Sclerosis
11%
Transcranial Direct Current Stimulation
10%
Sural Nerve
9%
Action Potential
8%
Eculizumab
8%
Reinnervation
8%
Hemoglobin A1c
8%
Conduction Velocity
8%
Muscle Atrophy
7%
Dysautonomia
7%
Risk Factor
7%
Diffusion Tensor Imaging
6%
Immunotherapy
6%
Transcranial Magnetic Stimulation
6%
Immunoglobulin G
6%
Fractional Anisotropy
6%
Randomized Controlled Trial
6%
Side Effect
5%
Nerve Function
5%
Charcot-Marie-Tooth Disease
5%
Insulin Aspart
5%
Histopathology
5%
Transient Ischemic Attack
5%
Skeletal Muscle
5%
Gamma-Aminobutyric Acid
5%
Myotonic Dystrophy
5%
Multiple Sclerosis
5%
Placebo
5%
Knee Flexors
5%
Blood Plasma
5%
Excitability
5%
